You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AMRX Sale Disclosure
Daly Jason B. · SEC Form 4 · Filed Aug 13, 2026
Sale
Calculated transaction value
$117.05K
Daly Jason B. EVP, Chief Legal Officer
AMRX
Transaction date
Aug 11, 2026
Public filing date
Aug 13, 2026
Filing lag
Filed 2 days later
AMRX daily price context
Close on/before transaction
$17.1
Aug 11, 2026
First close after public filing
$18.15
Aug 14, 2026
30-day return after filing
-5.12%
Through Sep 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 6,613 shares @ $17.7
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-056754
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$3.77M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. AMRX | Sale | Aug 12, 2026 | $3.65M |
| Amneal Pharmaceuticals, Inc. AMRX Current | Sale | Aug 11, 2026 | $117.05K |